{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By ANDREW POLLACK and EMMARIE HUETTEMAN", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}, {"rank": 2, "role": "reported", "firstname": "Emmarie", "organization": "", "lastname": "HUETTEMAN"}]}, "abstract": "Former Turing Pharmaceuticals chief executive Martin Shkreli refuses to answer questions during House Committee on Oversight and Government Reform hearing, exercising Fifth Amendment; Shkreli, who faces federal securities fraud charges, endures harsh criticism from lawmakers related to rising drug prices.  ", "type_of_material": "News", "word_count": "1292", "lead_paragraph": "Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.", "pub_date": "2016-02-05T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Martin Shkreli Invokes the Fifth Amendment During Grilling by Congress", "print_headline": "Hearing on Drug Pricing Delivers Spectacle but Few Answers"}, "snippet": "Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/02/05/business/drug-prices-valeant-martin-shkreli-congress.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Generic Brands and Products", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "House Committee on Oversight and Government Reform", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Schiller, Howard B", "name": "persons"}], "blog": [], "_id": "56b325bd38f0d82036f0aa60", "source": "The New York Times"}